ASP Isotopes Inc. (NASDAQ:ASPI) Short Interest Update

ASP Isotopes Inc. (NASDAQ:ASPI) was the target of a significant growth in short interest in September. As of September 30th, there was short interest totalling 9,570,000 shares, a growth of 16.8% from the September 15th total of 8,190,000 shares. Based on an average daily trading volume, of 992,600 shares, the days-to-cover ratio is currently 9.6 days. Currently, 23.2% of the company’s shares are sold short.

ASP Isotopes Stock Down 0.7 %

NASDAQ:ASPI traded down $0.02 during trading hours on Monday, hitting $3.03. The company’s stock had a trading volume of 376,296 shares, compared to its average volume of 816,169. ASP Isotopes has a 52-week low of $0.98 and a 52-week high of $5.67. The company has a current ratio of 4.00, a quick ratio of 4.00 and a debt-to-equity ratio of 2.06. The stock has a market capitalization of $156.84 million, a P/E ratio of -5.74 and a beta of 5.11. The stock has a fifty day moving average of $2.52 and a 200-day moving average of $3.25.

ASP Isotopes (NASDAQ:ASPI) last released its quarterly earnings data on Monday, August 19th. The company reported ($0.24) EPS for the quarter. The firm had revenue of $1.02 million during the quarter. On average, equities analysts forecast that ASP Isotopes will post -0.24 earnings per share for the current year.

Analyst Ratings Changes

Several equities analysts have commented on the stock. HC Wainwright decreased their price target on shares of ASP Isotopes from $5.50 to $4.50 and set a “buy” rating for the company in a research report on Wednesday, August 7th. Canaccord Genuity Group began coverage on ASP Isotopes in a report on Friday, October 4th. They issued a “buy” rating and a $4.50 target price for the company. Finally, Canaccord Genuity Group began coverage on ASP Isotopes in a report on Friday, October 4th. They set a “buy” rating and a $4.50 price target on the stock.

Institutional Inflows and Outflows

Hedge funds have recently modified their holdings of the stock. Vanguard Group Inc. grew its holdings in ASP Isotopes by 479.1% during the first quarter. Vanguard Group Inc. now owns 1,021,019 shares of the company’s stock worth $4,217,000 after acquiring an additional 844,705 shares during the period. Marshall Wace LLP grew its stake in shares of ASP Isotopes by 389.6% during the 2nd quarter. Marshall Wace LLP now owns 545,072 shares of the company’s stock worth $1,668,000 after purchasing an additional 433,734 shares during the period. Rathbones Group PLC increased its holdings in shares of ASP Isotopes by 27.5% in the 2nd quarter. Rathbones Group PLC now owns 195,915 shares of the company’s stock valued at $600,000 after purchasing an additional 42,243 shares in the last quarter. Renaissance Technologies LLC lifted its stake in shares of ASP Isotopes by 5.7% in the second quarter. Renaissance Technologies LLC now owns 171,800 shares of the company’s stock valued at $526,000 after purchasing an additional 9,200 shares during the period. Finally, Bank of New York Mellon Corp purchased a new stake in ASP Isotopes during the second quarter worth about $381,000. 16.80% of the stock is owned by hedge funds and other institutional investors.

ASP Isotopes Company Profile

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.